In another two symptomatic siblings with compound heterozygous GALNT3 mutations in exon 4 and 5, one exhibited features of FTC but the other demonstrated hyperostosis-hyperphosphatemia syndrome.26 Different GALNT3 mutations have been reported in the literature (Table 2). This evidence concerns the gene GALNT3 and hyperostosis.